Heat shock protein 90 subfamily is composed by two cytosolic isoforms known as Hsp90α and Hsp90β. Endothelial nitric oxide synthase (eNOS) is regulated by Hsp90, however the specific role of each Hsp90 isoform on NO production has not been established. This study was designed to evaluate the effect of Hsp90α and Hsp90β over-expression on eNOS/NO pathway. Rat Hsp90α and Hsp90β were cloned into pcDNA3.1(+) and transfected in human embryonic kidney cells (HEK-293). Hsp90α and Hsp90β transfection was corroborated by Western blot analysis and their effect on NO production (NO 2 /NO 3 ), eNOS protein and its phosphorylation at Ser1177 and Thr495, as well as Akt/PKB Ser473 phosphorylation was determined. The interaction of Hsp90α and Hsp90β with eNOS and the dimer/monomer ratio of Hsp90, as well as O 2 -generation were also assessed. After transfection, Hsp90α and Hsp90β levels were significantly increased in HEK-293 cells. The Hsp90α over-expression induced a significant increase in NO 2 / NO 3 levels, an effect that was associated with increased phosphorylation of eNOS Ser 1177 and Akt/ PKB Ser473, as well as with a greater Hsp90α dimerization. Noteworthy, pcHsp90β transfection reduced significantly NO 2 /NO 3 and increased O 2 -generation. These effects were associated with a reduction of eNOS dimeric conformation, increased eNOS Thr495 phosphorylation, reduced Akt/PKB phosphorylation, and by a greater amount of monomeric Hsp90β conformation. These data show for first time that Hsp90α and Hsp90β differentially modulate NO and O 2 -generation by eNOS through promoting changes in eNOS conformation and phosphorylation state.
Introduction
The heat shock protein subfamily of 90 kDa belongs to a group of highly conserved stress proteins and it is one of the most abundant proteins in eukaryotic cells, comprising 1-2% of the total protein under non-stress conditions [1] . Five isoforms of Hsp90 have been identified that differ in their cellular localization and abundance. In particular, Hsp90α and Hsp90β are the major cytosolic isoforms, sharing approximately 85% sequence identity 658 at the protein level. The structure of both Hsp90 isoforms consists of an N-terminal ATP-binding domain and a Cterminal dimerization domain, a middle domain linker region responsible for substrate-protein interactions, and a following charged domain that promotes the dimerization [2, 3] . The ATP binding site is the major target for Hsp90 inhibitors, but until now, specific inhibitors for Hsp90α or Hsp90β have not been developed.
In spite of the molecular similarity of these proteins important differences at the transcriptional and transductional levels have been described, suggesting that Hsp90α and Hsp90β might have differential roles in the cellular processes in which they are involved. Hsp90α transcription is tightly regulated by its promoter region, which contains several heat shock elements (HSEs) that are involved in the inducible gene expression of Hsp90α. However, differences between Hsp90α and Hsp90β are found in the promoter region; for Hsp90β HSEs are found in the first intron of the gene, and is not regarded as a highly inducible protein [4] . Another important difference is that Hsp90α easily dimerizes, whereas Hsp90β is mainly found as a monomer; the regions that facilitate these variations reside at the carboxyl-terminal amino acids of Hsp90 [2] . In this regard, it has been reported that the Hsp90 protein dimer, but not the monomer, stabilizes or activates different proteins known as Hsp90 client proteins in a nucleotide-dependent cycle. The Hsp90 cycle includes the following stages: an open, nucleotide-free form; a closed, ATP-bound structure; and a closed, ADPbound conformation [5] . The closed conformation had been suggested to form stable client-protein complexes, emphasizing the importance of Hsp90 dimerization for activating the client proteins [6] . Thus, Hsp90 is a crucial regulator of a vast array of cellular processes by interacting with more than 100 client proteins (http:// www.picard.ch/downloads/Hsp90interactors). Included among these proteins are steroid hormones, transcription factors, kinases, G proteins subunits, and endothelial nitric oxide synthase (eNOS).
eNOS is the primary source of nitric oxide (NO) in endothelial cells. It has been demonstrated that the interaction between Hsp90 and eNOS increases the activity of this enzyme, with greater NO production as a result. In contrast, the dissociation of these complex is not only associated with a reduction of NO synthesis but also turns eNOS into a superoxide generator [7] [8] [9] . Recent studies have shown that Hsp90 binds to the N-terminal oxygenase domain of eNOS present in residues 301-320 [9] . This interaction has a physiological connotation, because eNOS activity is regulated by at least four welldescribed mechanisms: 1) by enhancing calmodulin binding affinity to eNOS [10, 11] ; 2) by facilitating the ability of Ca 2+ /calmodulin to dissociate the interaction between caveolin-1 and eNOS, which reverses the inhibitory action of caveolin-1 on eNOS [12] ; 3) by propitiating eNOS serine 1179/1177 (bovine/human) phosphorylation, a translational modification that activates this enzyme [13] ; and 4) by recruiting Akt/PKB, which facilitates eNOS phosphorylation in the serine residue 1179 [14] . However, in the eNOS activation by Hsp90, the specific role of the α or β isoforms has not been completely addressed. To explore the specific participation of each Hsp90 isoform, this study was designed to evaluate the effect of Hsp90α or Hsp90β over-expression on the NO/eNOS pathway in human embryonic kidney (HEK-293) cells.
Materials and Methods

Plasmid constructs
Hsp90α and Hsp90β genes were amplified by PCR from cDNA synthesized from total rat RNA by using the forward primers 5' AAG GAA AAA AGC GGC CGC TCG TCA AGA TGC CTG AGG AA 3' and 5´ AAG GAA AAA AGC GGC CGC CTG CCA AGA TGC CTG AGG AA 3', respectively, and the reverse primers 5' CTA GTC TAG AGA GCC TTT AAT CCA CTT CTT CC 3' and 5' CTA GTC TAG ATT CTG GTG AAG CCT AGT CTA CTT C 5', respectively. In the forward primers, a Not I restriction site was included in the sequence, whereas in the reverse primers, a Xba I restriction site was introduced. The amplified fragments of 2260 for Hsp90α and 2220 bp for Hsp90β were cloned into the pcDNA3.1 (+) vector (Invitrogen) by using the Not I and Xba I restriction sites. The identities of the constructions were confirmed by automatic sequencing.
Hsp90 plasmid isolation
The isolation of the plasmids containing Hsp90α or Hsp90β sequences (pc-Hsp90α or pc-Hsp90β, respectively) was performed using the same general strategy for the largescale isolation described by Qiagen Science (Maryland, USA). The DNA was crudely checked for concentration and purity, using 1% agarose gel electrophoresis against molecular weight markers standards (λ DNA/Hind III fragments from Invitrogen, Carlsbad, CA), and it was then corroborated with the molecular weights reported for the Hsp90α or Hsp90β gene. The DNA plasmid yield was 10-15 µg in a 10-ml starting culture.
Cell Culture and Transfection
Human embryonic kidney 293 (HEK-293) cells were maintained in Dulbecco´s Modified Eagle´s Medium (DMEM) (GIBCO) containing 10% fetal bovine serum (FBS) (Life Technology), 100 U/ml penicillin and 100 µg/ml streptomycin at 37°C with 5% CO 2 . One day before the transfection, 5 x 10 5 HEK-293 cells were plated in 1 ml of DMEM medium per well in Cortes-González/Barrera-Chimal/Ibarra-Sánchez/Gilbert/Gamba/ Zentella/Flores/Bobadilla Cell Physiol Biochem 2010;26:657-668 six-well culture plates until they reached 90% confluence. To determine the amount of plasmid/liposome complex for obtaining the greater Hsp90α or Hsp90β over-expression, 0.5-2 µg of Hsp90α plasmid (pcDNA3.1/Hsp90α) or 4-8 µg of Hsp90β plasmid (pcDNA3.1/Hsp90β) was diluted in 100 µl of Opti-MEM® reduced serum medium (Invitrogen, Carlsbad, CA) and incubated for 15 min at room temperature. Next, 4 µl of Lipofectamine TM 2000 transfection reagent (Invitrogen, Carlsbad, CA) in 100 µl of Opti-MEM reduced serum was added, and the samples were maintained at room temperature for an additional 15 min. Thereafter, 200 µl of each Hsp90 complex was added to each well containing cells. The optimal transfection time for obtaining the higher over-expression of Hsp90α or Hsp90β was assessed at 24, 48 and 72 hours after transfection. Thus, the optimal conditions for Hsp90α and Hs90β over-expression in HEK-293 cells were 1 µg of pcHsp90α or 6 µg of pc-Hsp90β and 48 hr after transfection. Cells transfected with the pcDNA3.1(+) empty vector were included as controls in each experiment. All sets of transfections were performed at least in triplicate.
Small-interfering RNA (siRNA) transfection
The silencer pre-designed siRNAs corresponding to the target sequence of Hsp90α (Cat. number 4390818) or Hsp90β (Cat. number AM16831) were purchased from Ambion Inc. (Austin, TX). A silencer negative siRNA was used as a negative control (Cat. Number AM4613). In six-well plates, proliferating HEK-293 cells (at 70-90% confluency) were cultured and transfected with 100 nM of Hsp90α siRNA or Hsp90β siRNA. After 24 hr of transfection, Western blot analysis was carried out to examine the knockdown of targeted proteins and nitric oxide production.
Western Blot Analysis
Proteins from cell cultures transfected with pcDNA3.1/ Hsp90α, pcDNA3.1/Hsp90β pcDNA3.1, siRNA-Hsp90α, or siRNA-Hsp90β were extracted using a lysis buffer containing 50 mM HEPES, pH 7.4, 250 mM NaCl, 5 mM EDTA, 0.1% NP-40, a protease inhibitor cocktail (Complete, Roche) and phosphatase inhibitors, followed by centrifugation at 14000 rpm. Thereafter, the supernatants containing the proteins were recovered, and samples containing 20 µg of total protein were resolved by 8.5% SDS-PAGE and electroblotted onto polyvinylidene difluoride membranes (PVDF, Amersham Pharmacia Biotech, Psicataway, NJ, USA). Membranes were then blocked in 5% blotting solution (Bio-Rad) and incubated with their respective specific antibodies, as detailed below. The lower part of the membranes was incubated with a goat antiactin antibody (1:5000) overnight at 4°C (Santa Cruz Biotechnology, Santa Barbara, CA), whereas the upper membranes were incubated with polyclonal anti-rabbit Hsp90β (1:5000, Abcam Inc. Cambridge, MA), polyclonal anti-rabbit Hsp90α (1:5000, Abcam Inc. Cambridge, MA), anti-rabbit eNOS (1:500, Cell Signalling Technology), polyclonal anti-rabbit phosphorylated eNOS Ser1177 (1:500, Cell Signalling Technology), polyclonal anti-rabbit phospho-eNOS Thr495 (1:500, Cell Signalling Technology), polyclonal anti-human Akt (1:1000, Santa Cruz, Biotechnology), or polyclonal anti-human phospho-Akt Ser473 (1:1000, Santa Cruz, Biotechnology) antibodies. Membranes were then incubated with the secondary HRP-conjugated rat anti-rabbit IgG antibody (1:5000, Alpha Diagnostics, San Antonio, TX). Proteins were detected with an enhanced chemiluminescence kit (GE Healthcare Life Sciences, Amersham) and autoradiography. The bands were scanned for densitometric analysis.
Analysis of dimer and monomer conformation
The Hsp90α and Hsp90β dimer/monomer ratio was evaluated by Western blot for non-denatured proteins. Nonboiled samples containing 10 µg of total protein were resolved in 7.5% PAGE at 4°C. Proteins were transferred to a polyvinylidine difluoride membrane, and Western blot analysis for Hsp90α or Hsp90β was performed as described above. For eNOS dimer/monomer conformation analysis, non-boiled samples containing 50 µg of total protein were resolved in a 6% SDS-PAGE at 4°C. Then, proteins were transferred to a polivinylidine difluoride membrane, and Western blot analysis for eNOS was performed as described above.
Immunoprecipitation (IP) analysis
Subconfluent proliferating cells in 300-mm 2 dishes were harvested, and whole cell extracts were prepared and subjected to IP. After 48 h of transfection, the cells were washed with 2 ml of phosphate buffered saline (PBS), and lysis ELB buffer was added. Cell debris was removed from the cell lysates, and eNOS protein was immunoprecipitated using a protein G immunoprecipitation kit (Sigma Aldrich, Inc. St Louis, MO). Each IP was performed using 3 µg of eNOS antibody (BD Transduction Laboratories) and 1 mg of cell protein. The immunoprecipitated proteins were eluted by boiling in Laemmli sample buffer, separated by 8.5% SDS-PAGE, transferred onto PVDF membranes and subjected to Western blotting. The membrane was blocked with 5% non-fat milk in TBS-Tween (0.1%) and then immunoblotted for eNOS and Hsp90α Abcam Inc., Cambridge, MA), as previously described. Next, the membranes were stripped and reprobed with anti-Hsp90β (1:5000 dilution, Abcam Inc., Cambridge, MA) and eNOS (1:500 dilution) antibodies to demonstrate equal amounts of eNOS immunoprecipitation in all samples.
Hydrogen Peroxide Determination
The amount of hydrogen peroxide was determined in whole cell lysates (WCL) from each group of cells transfected using the Amplex Red Hydrogen Peroxide/Peroxidase Assay kit (Invitrogen 29851 Willow Creek Road), according to the instructions provided. Briefly, 50 µl of each WCL or standard curve (H 2 O 2 1-10 µM) was mixed with 50 µl of the Amplex Red reagent/HRP in a microplate. The samples were incubated for 30 minutes protected from light to allow the reaction between H 2 O 2 and the Amplex reagent to occur. The plate was read at 560 nm. The amount of H 2 O 2 detected in the samples is expressed as nM/µg of protein. Kit (Oxford Biomedical Research Inc., Oxford, MI). This assay consists of reducing the sample nitrates to nitrites with the use of nitrate reductase, followed by nitrite quantification with the Griess reaction and detection at 540 nm. The protein concentration in each WCL was determined by the Lowry assay (Bio Rad, Hercules, CA) and in duplicate. The concentration of nitrites in the WCL is expressed as µM/µg of protein.
Measurement of NO release or NO Assay
Superoxide anion detection
Intracellular superoxide detection was assessed by hydroethidine staining (Polysciences, Inc., Warrington, PA). A stock solution of hydroethidine (HE) was prepared by dissolving 7 mg of HE in 1 mL of N,N-dymethylacetamide. The working solution was prepared by the addition of 20 µl of HE to 10 ml of PBS, and this mixture was filtered through a 0.22-mM Millipore filter. After 48 h of transfection, the medium was removed, and the cells were washed three times with PBS. The staining solution was added, and the cultures were incubated for 15 minutes at room temperature and protected from the light. Thereafter, the staining solution was removed, and the cells were washed three times. The cells were re-suspended in PBS for flow cytometry analysis. Ten thousand cells from each transfection group were analyzed in a FACScan cytometer (Becton Dickinson), and the fluorescence intensity was determined using an excitation of 535 nm and an emission of 610 nm. The data were analyzed using the Cell Quest program.
Statistical analysis
Results are presented as means ± SE. The significance of the differences among groups was tested by ANOVA using Bonferroni's correction for multiple comparisons and between two groups by the un-paired T test. Statistical significance was defined as a p value <0.05.
Results
Hsp90α cloning and HEK-293 transfection
The Hsp90α gene was amplified from rat kidney cDNA using specific primers, as detailed above. After the proper purification of PCR product of ≈ 2260 bp, rat Hsp90α (rHsp90α) was cloned into the pcDNA3.1(+) expression vector via a multi-cloning site by using Xba I and Not I sites. After Xba I and Not I digestion, two fragments were obtained, with the larger corresponding to the pcDNA3.1 vector and the smaller to the Hsp90α sequence (data not shown). The sequence of Hsp90α was corroborated by automatic sequencing that revealed 99% identity with the rat sequence reported for Hsp90α in GenBank (number AJ428213.1). Similarly, Hsp90α was cloned in the expression vector pcDNA3.1/NT-GFP (which codifies for the green fluorescent protein). Epifluorescence inverted microscopy was employed to detect the transfection efficiency. It was shown that 80% of HEK-293 cells were able to express the GFP (data not shown).
Different concentrations of Hsp90α plasmid were transfected into HEK-293 cells to determine the optimal conditions for pcDNA 3.1/Hsp90α transfection. The upper panel of Fig. 1A shows the insets of the Western blot analysis for Hsp90α and β actin. Two bands in the Hsp90α Western blot were detected. The larger band corresponds to the human endogenous Hsp90α that is expressed in HEK-293 cells, and the lower band corresponds to the transfected rat Hsp90α. Greater rat Hsp90α over-expression was detected when the cells were transfected with 1 µg of pcDNA 3.1/Hsp90α without changes in the endogenous Hsp90α expression, as shown in Fig. 1B . In addition, different times after transfection were assessed to determine the greatest Hsp90α overexpression. As shown in Fig. 1C , the higher rat Hsp90α expression was obtained after 48 h, without changes in human Hsp90α expression (Fig. 1D ). Other groups of cells were transfected with the optimal conditions, then Hsp90α and Hsp90β protein levels were detected by Western blot analysis. As expected, pcDNA3.1/Hsp90α transfection increased Hsp90α protein levels, as shown in Fig. 1E , without altering Hsp90β protein levels as is represented in Fig. 1F . These results shown that Hsp90α and Hsp90β antibodies were specific to detect each Hsp90 isoform studied.
Hsp90β cloning and HEK-293 transfection
The Hsp90β gene was also amplified from rat kidney cDNA using specific primers, as detailed above. The PCR product of ≈2220 bp was purified and cloned into pcDNA3.1(+) using Not I and Xba I restriction sites. The Hsp90β sequence was first corroborated by restriction analysis; for this, the vector was digested with Xba I and Not I, Xba I, Sac I, EcoR I, Kpn I, and Mfe I. When the vector was digested with Xba I and Not I, two fragments were obtained, with the larger corresponding to the pcDNA3.1 vector and the smaller to Hsp90β (data not shown). With the rest of the enzymes, we obtained the expected specific size fragments for Hsp90β (these size fragments are not obtained when Hsp90α was digested with these enzymes). The sequence was also corroborated by automatic sequencing, which revealed 100% identity with the rat sequence reported for Hsp90β in GenBank (number DQ022068.2). To determine the optimal conditions for Hsp90β over-expression, HEK-293 cells were transfected with different plasmid concentrations. As shown in Fig. 2A , maximum overexpression was detected when cells were transfected with 6 µg of pcDNA 3.1/Hsp90β a unique band of Hsp90β was detected corresponding to both human endogenous and rat transfected sequence. In addition, the best period of time to obtain maximum over-expression with 6 µg of plasmid was at 48 h after transfection (Fig. 2B) . Independent groups of cells were transfected with the optimal conditions, and Hsp90α and Hsp90β protein levels were detected by Western blot analysis. As expected, pcDNA3.1/Hsp90β transfection increased Hsp90β by ≈2-fold, as shown in Fig. 2C , without modifying the Hsp90α protein levels (Fig. 2D) .
Effects of Hsp90α and Hsp90β over-expression on the eNOS/NO pathway
Because it has been shown that Hsp90 regulates eNOS activity [10] [11] [12] [13] 15] , we studied the specific role of Hsp90α and Hsp90β over-expression in nitric oxide production. First we assessed eNOS protein levels in untransfected HEK-293, as Fig. 3 shows these cells do express eNOS, as well as Hsp90α and Hsp90β. This finding was further confirmed by the measurement of NO 2 /NO 3 levels in these cells. Figure 4A shows the percentage changes in NO 2 /NO 3 levels in groups transfected with Hsp90α or Hsp90β, compared with the cells that were transfected with the empty pcDNA vector. Hsp90α over-expression produced a significant increase Cortes-González/Barrera-Chimal/Ibarra-Sánchez/Gilbert/Gamba/ Zentella/Flores/Bobadilla Cell Physiol Biochem 2010; 26:657-668 in NO metabolites (from 0.29 ± 0.01 to 0.61 ± 0.03 µM/ µg of protein) that represented an increase of 113.3%. Intriguingly, Hsp90β over-expression produced the opposite effect, such that NO 2 /NO 3 levels were significantly reduced in transfected HEK-293 cells (0.13 ± 0.01 µM/µg of protein). The specificity of the observed effects was studied by reducing the endogenous Hsp90α and Hsp90β expression by using specific siRNAs for these proteins. Therefore, other groups of cells were transfected with the corresponding siRNA/Hsp90α or siRNA/ Hsp90β. We assessed the Hsp90α and Hsp90β expression after 24 to 72 h after respective siRNAs transfection and from these results the experiments with siRNAs were performed after 48h (data not shown). When the NO 2 /NO 3 levels were evaluated, we observed that siRNA/Hsp90α transfection produced a significant reduction in NO metabolites, by 36.5 % as is depicted in Fig. 4A . In contrast, siRNA/Hsp90β transfection was associated with a significant increase in NO 2 /NO 3 levels, by 74.7%. These data strongly suggest that Hsp90α and Hsp90β have differential roles in regulating eNOS activity.
We examined whether these differences were propagated by changes in the interaction of Hsp90α or Hsp90β with eNOS. As shown in Fig. 4B , it was not the case, as the IP-Western blotting analysis revealed that eNOS was able to associate with both Hsp90α and Hsp90β, suggesting that the reduction of eNOS activity by Hsp90β did not result from an inability of this chaperone to associate with eNOS.
To evaluate if the differential modification of NO production induced by Hsp90α and Hsp90β overexpression was mediated by changes in eNOS expression and its phosphorylation, eNOS protein levels and the phosphorylation of serine 1177 and threonine 497 residues of eNOS were evaluated in transfected HEK-293 cells by Western blot analysis using the corresponding phosphoantibodies. The eNOS protein levels in HEK-293 cell cultures was not modified by either Hsp90α or Hsp90β transfection, as evident in the top inset and by the densitometric analysis shown in Fig. 4C . A significant increase in the immune-detection signal of phosphorylated Ser1177 was observed in the cells that over-expressed Hsp90α, an effect that was not seen in Hsp90β-transfected cells (Fig. 4D) . The mean ratio of phosphorylated Ser1177 eNOS/β-actin in pc-Hsp90α-transfected cells was 0.83 ± 0.08, compared to 0.32 ± 0.04 and 0.36 ± 0.05 AU for pc-Hsp90β and pcDNA3.1 empty vector, respectively. In contrast, the transfection of pc-Hsp90β significantly increased Thr495 eNOS phosphorylation (Fig. 4E) , but overexpression of Hsp90α did not modify the phosphorylation of this eNOS residue. The mean ratio of phosphorylated Thr495-eNOS/β-actin in Hsp90β and pcDNA3.1-transfected cells was 0.86 ± 0.1, compared to 0.50 ± 0.05 and 0.55 ± 0.09 in liposomes and Hsp90α-transfected cells, respectively. Because it has been reported that Hsp90 plays an important role in the activation of p-Akt/PKB [16] and because this kinase it is able to phosphorylate Ser1177 of eNOS [17, 18] , we evaluated the effect of overexpressing Hsp90α or Hsp90β on Akt/PKB activation. As shown in Figure 4F , the transfection of either Hsp90α or Hsp90β did not modify the Akt/PKB protein levels, but a different effect was observed for the phosphorylation of this kinase. Thus, Hsp90α over-expression was associated with a significant increase in Akt/PKB phosphorylation, whereas Hsp90β over-expression induced a significant reduction in the amount of phosphorylated Akt/PKB.
Moreover, it has been previously shown that eNOS is able to generate superoxide anion when it is phosphorylated at Thr-497; thus, we assessed the effect of Hsp90α or Hsp90β over-expression on the cellular oxidative stress state by measuring the hydrogen peroxide levels in HEK-293 cell cultures. Figure 5A shows the H 2 O 2 levels in WCL, expressed as nmol/µg of protein. It is noteworthy that the H 2 O 2 levels increased by two-fold when Hsp90β was over-expressed, an effect that was not observed when pc-Hsp90α was transfected. To further confirm these findings, we performed hydroethidine (HE) staining to detect intracellular superoxide anion generation by flow cytometry analysis. Figure 5B shows the representative histograms of each transfected group, and Figure 5C and 5D show the percentage of stained cells and the quantification of the mean fluorescence intensity (MFI), respectively. The HE staining confirmed that Hsp90β over-expression induced a higher generation of superoxide anion, as shown by the increase in the percentage of cells positive for HE staining (from 2.7 ± 0.9 to 9.0 ± 0.8 %, p=0.002) and by the MFI measurement (from 1 ± 0.06 to 1.6 ± 0.03 AU, p=0.002).
Because the dimeric Hsp90 conformation has been shown to be necessary for interactions with the client proteins, the monomeric/dimeric ratio in HEK-293 cells transfected with Hsp90α and Hsp90β was evaluated. The insets in Fig. 6A and Fig. 6B show Westerns blot under non-denaturing conditions of proteins extracted from Hsp90α and Hsp90β-transfected cells, respectively. Typically, most of the Hsp90α was found in its dimeric conformation (Fig. 6A ), in contrast with the Hsp90β which was found mainly in the monomeric conformation (cells transfected with the empty vector) as is shown in Fig.  6B . When the monomeric/dimeric ratio was evaluated in cells transfected with either pc-Hsp90α or pc-Hsp90β most of the Hsp90α was found in its dimeric conformation. In addition, a greater amount of this protein was detected in the cells that were transfected with pcHsp90α. In contrast, when Hsp90β was over-expressed, most of the protein was found in its monomeric conformation, and again, more monomeric Hsp90 was observed in the cells that were transfeceted with pcHsp90β (Fig. 6B) .
It has been previously reported that dimeric eNOS conformation is required for a suitable NO production [19] , thus we evaluated if Hsp90α and Hsp90β overexpression modify the dimeric/monomeric eNOS conformation. The upper panel of Figure 7 shows the inset of eNOS Western blot analysis in non-denaturating conditions from HEK-293 cells transfected with empty vector, pcHsp90α and pcHsp90β respectively. The lower panel depicts the densitometric analysis of dimeric and monomeric bands of eNOS, together with the resulting dimeric/monomeric ratio. The reduction of NO synthesis induced by Hsp90β over-expression was associated with a significant decrease in eNOS dimeric conformation, with the concomitant eNOS dimeric/monomeric ratio reduction. This effect was not seen in pcHsp90α transfected cells.
Discussion
Hsp90 plays a key role in cellular signal transduction networks, as it is essential for maintaining the activity of numerous signaling proteins. One of the most studied Hsp90 interactions is that established with eNOS. Several studies have shown that Hsp90 regulates eNOS activity through modulations of the following processes: helping to activate eNOS by dissociating it from caveolin-1; enhancing eNOS enzymatic activity by promoting its dimerization; facilitating the activating eNOS phosphorylation; and modulating the release of NO vs. superoxide by eNOS [10] [11] [12] [13] . Furthermore, Hsp90 has also been proposed to facilitate the calcineurin-dependent dephosphorylation of the residue Thr495 site of eNOS, which contributes to enhance its enzymatic activity [15] . Therefore, Hsp90 plays a critical role in vascular NO synthesis through the regulation of eNOS activity. In this regard, we have recently shown that Hsp90 inhibition with radicicol, that reduced Hsp90 interaction with their client proteins, produced a significant reduction in renal plasma flow and glomerular filtration rate, an effect that was associated with a decreased urinary excretion of nitrites and nitrates (NO 2 /NO 3 ), suggesting that the disruption of eNOS-Hsp90 complex reduced renal NO synthesis [20] . In addition, previous studies have shown that the disruption of eNOS/Hsp90 complex promotes not only the reduction anion by eNOS [8, 9, 21, 22] . Even though there is enough evidence about the Hsp90/eNOS coupling and uncoupling in NO and O 2 -generation, respectively, the specific role of Hsp90α and Hsp90β in this pathway have not been completely addressed. Two previous studies [7, 23] suggested that transfection of Hsp90β induces an increase in NO production in COS and pulmonary arterial endothelial cells (PAEC). However, results from these studies are hard to evaluate because the Hsp90 antibody that was used recognizes both isoforms and thus Hsp90β overexpression was not demonstrated. In addition, in one of the studies [23] , the effect of empty adenovirus transfection was not evaluated. Other studies in which the interaction between eNOS and Hsp90 was enhanced by a transient Hsp90 transfection, did not specified which isoform of Hsp90 was used for the transfection [15, 24] .
In the present study, the participation of Hsp90α or Hsp90β in the eNOS/NO/O 2 -pathway was evaluated by inducing the over-expression of each isoform in HEK-293 cells. For this issue, we cloned Hsp90α and Hsp90β into an expression vector and the over-expression was gotten by transitory transfection. The pc-Hsp90α transfection produced a significant elevation in Hsp90α without modifing Hsp90β protein levels. Similarly, in cells transfected with pc-Hsp90β, the levels of this protein were significantly enhanced, whereas the endogenous Hsp90α protein levels were not affected. Therefore, the effects seen in this study on the NO/eNOS pathway were solely induced by the transitory over-expresion of each Hsp90 isoform.
Accordingly, we observed that Hsp90α overexpression was associated with a significant increase in NO 2 /NO 3 levels. Quite interestingly, pc-Hsp90β transfection produced the opposite effect; thus, NO metabolites were significantly reduced in HEK-293 cells. These findings were supported by results using respective siRNAs of Hsp90α or Hsp90β. Consequently, when Hsp90α expression was reduced by this strategy, the NO metabolites were significantly decreased. In contrast, when HEK-293 cells were transfected with Hsp90β siRNA, the NO 2 /NO 3 levels were significantly enhanced. In this regard, these results suggest that cystosolic Hsp90 isoforms exert distintive functions in the NO pathway, in which Hsp90α positively regulates NO synthesis whereas Hsp90β has a contrary effect.
To begin to understand the mechanisms by which Hsp90α and Hsp90β have differential roles in NO production, we evaluated the eNOS protein levels and the eNOS phosphorylation of two main residues that are implicated in this enzyme activity. We found that eNOS protein levels were not modified when the HEK-293 cells were transfected with either Hsp90α or Hsp90β, however, profound changes in its phosphorylation state were observed. Hsp90α over-expression was associated with a significant increase in eNOS-activating phosphorylation (Ser1177), whereas Hsp90β over-expression produced an increase in the eNOS-inactivating phosphorylation (Thr495). In this regard, previous studies have shown that increased eNOS phosphorylation at Thr495, as caused by eNOS-Hsp90 uncoupling, resulted in lesser NO production [20, 25, 26] . In support of this, Lin et al. [27] reported that the T495A eNOS mutant, which cannot be phosphorylated at this site, was able to enhance eNOS activity. The immunoprecipitation analysis performed in this study revealed that both Hsp90α and Hsp90β are able to associate with eNOS, suggesting that these two Hsp90 isoforms exert differential eNOS regulation through modulating eNOS phosphorylation. Incidentally, it has been shown that eNOS activation by Hsp90 is mediated, in part, by a scaffolding effect that enhances the interaction between eNOS and the active serine/threonine kinase Akt/PKB [10] , which, in turn, promotes eNOS Ser1177 phosphorylation. Intriguingly, Akt/PKB activity is also regulated by Hsp90 through the prevention of PP2A-mediated Akt dephosphorylation [16] . Consequently with these previous findings, we observed that pc-Hsp90α transfection increased Akt/PKB phosphorylation, suggesting that the greater NO synthesis observed in these transfected cells was in part due to an enhanced Akt/PKB activity, resulting in eNOS Ser1177 phosphorylation. Of note, pc-Hsp90β transfection induced a significant reduction of Akt/PKB phosphorylation, which was associated with an increase in the inactivating eNOS phosphorylation (Thr495), and these findings were associated with a significant reduction in NO production. Thus, our results suggest that another way by which Hsp90α and Hsp90β differentially regulate eNOS is by modifying Akt/PKB phosphorylation.
Several studies have shown that eNOS Thr495 phosphorylation promotes the superoxide anion (O 2 -) generation instead of NO [8, 9, 23, 28, 29] . To explore the significance of the increased eNOS Thr495 phosphorylation induced by pc-Hsp90β transfection on O 2 -generation, the levels of peroxide hydrogen and O 2 -anion were evaluated in transfected HEK-293 cells. The reduction of NO induced by Hsp90β over-expression was associated with a significant increase in hydrogen peroxide, suggesting a greater O 2 -generation. These results were confirmed by measuring cellular O 2 -by cytofluorometry, in which a significant increase in the generation of this anion was observed in HEK-293 cells transfected with pc-Hsp90β, an effect that was not seen following transfection with pc-Hsp90α. Altogether, these results suggest that Thr 497 phosphorylation switches the ability of eNOS to produce O 2 -, and, interestingly, this effect seems to be promoted by the association of Hsp90β with eNOS.
The dimeric molecular conformation of Hsp90 is required for the activation and stabilization its client proteins. Hsp90 consists of a C-terminal dimerization domain, a middle domain (which may interact with substrate proteins), and an N-terminal ATP-binding domain. The activation process depends on the hydrolysis of ATP by Hsp90. Thus, the ability of Hsp90 to interact with its client proteins is strongly determined by its conformational state [3, 30, 31] . In this sense, Hsp90β human and mouse is less frequently found as a dimer than Hsp90α. The impeded ability of Hsp90β to dimerize is related to the 16 amino acid substitutions located in the 561-685 amino acid region of the C-terminal dimerization domain [32] ; specifically, Thr566 and Ala629 seem to be responsible for the reduced ability of Hsp90β to dimerize [33] . Here, we evaluated the monomer/dimer ratio of Hsp90α and Hsp90β in HEK-293 cells before and after pc-Hsp90α or pc-Hs90β transfection. As has been previously reported, we found that Hsp90α was predominantly in its dimeric molecular conformation, whereas Hsp90β persisted in a monomeric conformation in the cells that were transfected with the empty vector. When Hsp90α was over-expressed, most of the protein was found in the dimeric form, without changes in the Hsp90β monomer form. In contrast, the over-expression of Hsp90β rendered a greater proportion of the monomeric conformation. These results suggest that both Hsp90 isoforms are able to associate with eNOS, but the conformation state of Hsp90 seems to be a regulator of eNOS ability to produce NO or O 2 -. Because Hsp90 is also able to interact with neuronal and inducible NOS [34] [35] [36] , we can not exclude the participation of other NOS isoforms in the NO production seen when Hsp90α or Hsp90β were over-expressed.
The differential regulation of eNOS by Hsp90α and Hsp90β seems not only to be explained by changes in eNOS phosphorylation or Hsp90 conformation, but also, Hsp90β over-expression induced a significant reduction in eNOS active conformation. Thus, the reduction in NO synthesis observed in HEK-293 cells transfected with pcHsp90β was associated with a lesser dimeric conformation of eNOS, suggesting that this is another mechanism by which Hsp90β differentially regulates eNOS activity.
Taken together, our results suggest that to obtain a suitable NO synthesis, the formation of the dimeric conformation of Hsp90α is required, which not only allows eNOS dimerization, but also helps to eNOS phosphorylation at Ser1177 by Akt/PKB. In contrast, when Hsp90β is predominantly found as a monomer, it affects eNOS pathway through two different mechanisms: by reducing Akt/PKB phosphorylation/activity and by propitiating the inactive eNOS conformation which in turns is associated with eNOS phosphorylation at Thr495, an effect that causes eNOS to produce O 2 -instead of NO. These findings could have important implications for abnormal vascular physiology in which the generation of the superoxide anion is increased and nitric oxide availability is reduced.
